Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss.
about
The role of d-dimer as first marker of thrombophilia in women affected by sterility: implications in pathophysiology and diagnosis of thrombophilia induced sterilityRecurrent miscarriage syndrome and infertility due to blood coagulation protein/platelet defects: a review and update.Endometrial gene expression in early pregnancy: lessons from human ectopic pregnancy.Meta-analysis of the association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss.Association of plasminogen activator inhibitor-1 and angiotensin converting enzyme polymorphisms with recurrent pregnancy loss in Iranian women.Spontaneous thrombolysis: a forgotten determinant of life or death.The cost-benefit ratio of screening pregnant women for thrombophilia.Combination of thrombophilic gene polymorphisms as a cause of increased the risk of recurrent pregnancy loss.The association between thrombophilic gene mutations and recurrent pregnancy loss.A likelihood model that accounts for censoring due to fetal loss can accurately test the effects of maternal and fetal genotype on the probability of miscarriage.Inherited thrombophilia and recurrent pregnancy loss.Etiopathogenesis of Sheehan's Syndrome: Roles of Coagulation Factors and TNF-Alpha.Association between plasminogen activator inhibitor-1 gene polymorphisms and recurrent pregnancy loss: a systematic review and meta-analysis.The Association of Plasminogen Activator Inhibitor Type 1 (PAI-1) Level and PAI-1 4G/5G Gene Polymorphism with the Formation and the Grade of Endometrial Cancer.Pregnancy loss, polycystic ovary syndrome, thrombophilia, hypofibrinolysis, enoxaparin, metformin.Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome.Commentary on current trends of reproductive immunology practices in IVF: a first world survey using IVF-worldwide.com.Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss.Toward optimal set of single nucleotide polymorphism investigation before IVF.Genetics of suspected thrombophilia in Serbian females with infertility, including three cases, homozygous for FII 20210A or FV 1691A mutations.Thrombophilic gene polymorphisms and recurrent pregnancy loss in Greek women.Analysis of thrombophilic genetic mutations in patients with Sheehan's syndrome: is thrombophilia responsible for the pathogenesis of Sheehan's syndrome?Thrombophilic mutations and polymorphisms, alone or in combination, and recurrent spontaneous abortion.The Val34Leu genetic variation in the A subunit of coagulation factor XIII in recurrent spontaneous abortion.Analysis of plasminogen activator inhibitor-1, integrin beta3, beta fibrinogen, and methylenetetrahydrofolate reductase polymorphisms in Iranian women with recurrent pregnancy loss.Combined thrombophilic mutations in women with unexplained recurrent miscarriage.Risk for early pregnancy loss by factor XIII Val34Leu: the impact of fibrinogen concentration.
P2860
Q24801470-9C4932DF-3F26-40CD-AA8E-10B7B0F29028Q33364713-7F04307B-9178-49DD-B869-87BCD0C5C3C6Q33899735-8E40DE46-2081-4A62-8FBC-51A55118ED2FQ35489121-907DAD29-4E51-44C6-9F49-1299069D5F13Q36343261-90BEC00F-D0B6-417F-BE03-3888ADD51BB1Q36588653-2FC0BECA-A503-4DFE-8895-049B51C5A683Q36969463-63C9F1F6-CA43-4CCF-B403-687C99A24AB8Q37035275-7E740BC4-733A-49A2-8D69-87DA41F10826Q37300080-8A5ECED7-AA25-44F2-877A-4878495240C0Q37371093-5E44D591-080C-41F1-B9DF-7CFF04F8E021Q37639529-ACE0D103-3EB3-4287-AAA8-4A9549AE14AFQ37730732-9032A2B7-10E2-4046-8DA8-61056DFAF143Q38253818-E50D8ED2-BD13-4202-A466-D224827C3560Q38902224-B11A7A7C-AEAC-4425-9B31-E2EDFA5627E7Q45117379-A35406D9-ECCA-42A1-AC58-34DC5EC331C9Q45918351-3C018363-53F5-49C1-8564-D13B9E502846Q45948493-6949CA1C-43F3-4569-B643-1863344F8D7EQ46148241-19A1073F-06BF-4B15-82AC-48219C96176CQ47659103-4384197A-3681-4071-B6A0-084FCBD5A73EQ47944733-CF82BB1A-F565-4214-859A-CF104A6639CAQ48294531-20DED332-07D5-45AF-9954-E45778BC67ABQ51531350-F613310D-C5D0-4803-B784-DF226FAB8D05Q54226171-13A50786-2AAF-48C7-9F73-9F6AC9788668Q54374360-F78B1218-0122-4478-91CD-1606E696B4D2Q54392340-9EFE1255-3A86-43DD-B537-789B8A7E71C9Q54562850-AC9522C1-3D0D-4279-94DB-C482BA195C5BQ54620664-EC008494-B2BA-4FE5-BB22-F6DF896FD54B
P2860
Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Plasminogen activator inhibito ...... ysis and early pregnancy loss.
@en
Plasminogen activator inhibito ...... ysis and early pregnancy loss.
@nl
type
label
Plasminogen activator inhibito ...... ysis and early pregnancy loss.
@en
Plasminogen activator inhibito ...... ysis and early pregnancy loss.
@nl
prefLabel
Plasminogen activator inhibito ...... ysis and early pregnancy loss.
@en
Plasminogen activator inhibito ...... ysis and early pregnancy loss.
@nl
P2093
P356
P1433
P1476
Plasminogen activator inhibito ...... ysis and early pregnancy loss.
@en
P2093
Anne Moritz
Astrid Dossenbach-Glaninger
Christian Oberkanins
Johannes Huber
Martin Dossenbach
Michael van Trotsenburg
Pierre Hopmeier
Walter Krugluger
P304
P356
10.1373/49.7.1081
P407
P577
2003-07-01T00:00:00Z